High-dose carboplatin, thiotepa and cyclophosphamide (CTC) with peripheral blood stem cell support in the adjuvant therapy of high-risk breast cancer: a practical approach-Reference-Cited by-同舟云学术

High-dose carboplatin, thiotepa and cyclophosphamide (CTC) with peripheral blood stem cell support in the adjuvant therapy of high-risk breast cancer: a practical approach

Published:1995-04 Issue:4 Volume:71 Page:857-862
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

van der Wall E,Nooijen WJ,Baars JW,Holtkamp MJ,Schorangel JH,Richel DJ,Rutgers EJT,Slaper-Cortenbach ICM,van der Schoot CE,Rodenhuis S

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/bjc1995165.pdf

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Factors influencing catheter-related infections in the Dutch multicenter study on high-dose chemotherapy followed by peripheral SCT in high-risk breast cancer patients;Bone Marrow Transplantation;2008-07-14

2. Efficacy of high-dose alkylating chemotherapy in HER2/neu-negative breast cancer;Annals of Oncology;2006-04

3. The use of high-dose cyclophosphamide, carmustine, and thiotepa plus autologous hematopoietic stem cell transplantation as consolidation therapy for high-risk primary breast cancer after primary surgery or neoadjuvant chemotherapy;Biology of Blood and Marrow Transplantation;2004-11

4. High-Dose Chemotherapy with Hematopoietic Stem-Cell Rescue for High-Risk Breast Cancer;New England Journal of Medicine;2003-07-03

5. Toxicity of the high-dose chemotherapy CTC regimen (cyclophosphamide, thiotepa, carboplatin): the Netherlands Cancer Institute experience;British Journal of Cancer;2003-06